Small Molecules

23 Jun 2007 Rasilez(R), an important new treatment for high blood pressure, receives positive opinion recommending European Union approval
23 Jun 2007 Pfizer's Lyrica Receives FDA Approval for Fibromyalgia
22 Jun 2007 S*BIO becomes Singapore's first biotech company to initiate clinical trial of novel anti-cancer drug
22 Jun 2007 Shire Receives Approvable Letter from FDA for INTUNIV(TM) (guanfacine) Extended Release, a Nonstimulant for the Treatment of ADHD
22 Jun 2007 LifeCycle Pharma to Initiate Phase II Clinical Trial of LCP-Tacro for Organ Transplantation
22 Jun 2007 FDA Issues Approvable Letter for RISPERDAL(R) to Treat Adolescents with Schizophrenia and Children and Adolescents with Bipolar Mania
22 Jun 2007 LAB International licenses Fentanyl TAIFUN(R) to Janssen Pharmaceutica NV for Europe
22 Jun 2007 VIVUS Completes End of Phase 2 Meeting with the FDA for Qnexa, a Treatment for Obesity
22 Jun 2007 Cethromycin Achieves Primary Endpoint in Pivotal Phase 3 Pneumonia Clinical Trial
22 Jun 2007 4SC AG achieves proof of concept for drug candidate SC12267
22 Jun 2007 Exforge(R) receives final US approval as new and powerful treatment option for patients with high blood pressure
22 Jun 2007 Kinex Files IND for KX2-391 with the US Food and Drug Administration
22 Jun 2007 Icagen Receives Notification from McNeil of Termination of Collaboration Agreement
21 Jun 2007 Metabasis Therapeutics Announces Initiation of a Clinical Trial for MB07811, Its Novel Product Candidate for the Treatment of Hyperlipidemia
21 Jun 2007 Array BioPharma Reports New Clinical Data on Its Anti-Inflammatory Drugs
21 Jun 2007 Anadys Pharmaceuticals Nominates ANA598, a Small-Molecule, Non-Nucleoside Inhibitor of The NS5b Polymerase, as a Candidate for Clinical Development in Chronic Hepatitis C Virus Infection
21 Jun 2007 Pipeline update – CNS 7056
21 Jun 2007 Alexza Pharmaceuticals Expands Staccato(R) Migraine Product Portfolio
21 Jun 2007 Coley Pharmaceutical Group Announces Pfizer's Discontinuation of Clinical Trials for PF-3512676 Combined with Cytotoxic Chemotherapy in Advanced Non Small Cell Lung Cancer
21 Jun 2007 Pfizer Receives Approvable Letter From FDA For Maraviroc
21 Jun 2007 Theravance Announces Enrollment of Last Patient in Phase 3 Hospital-Acquired Pneumonia Clinical Program with Investigational Antibiotic, Telavancin
21 Jun 2007 Panacos Announces Substantial Antiviral Response in Bevirimat 250 mg Cohort, Data Support Further Dose Escalation in Phase 2b Study
20 Jun 2007 OSI Pharmaceuticals Begins Clinical Development Program of OSI-906 in Patients with Advanced Solid Tumors
20 Jun 2007 Bayer and Onyx submit new european marketing authorization application to EMEA for Nexavar to treat liver cancer
20 Jun 2007 FDA Grants Priority Review for Bristol-Myers Squibb's Investigational Oncology Treatment Ixabepilone

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2019 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up